Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897364 · ClinicalTrials.gov registry record
Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers
A clinical trial of Lung Cancer and Precancerous Condition, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 112
- Enrollment target
- 1
- Study location
NCT00897364: Completed study of Lung Cancer and Precancerous Condition, sponsored by University of Colorado, Denver.
NCT00897364 is a study of Lung Cancer and Precancerous Condition that has completed, run by University of Colorado, Denver. The registered enrollment target is 112 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897364, a study of Lung Cancer and Precancerous Condition, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Studying samples of tissue from smokers and non-smokers in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This phase II study is looking at biomarkers in the nose, throat, and lung tissue of smokers and non-smokers.
Primary Outcome
Evaluation of both Molecular and Biochemical profiles of normal non-smokers, smokers with no apparent disease (no airflow obstruction or cancer), and smokers with airflow obstruction and abnormal sputum cytology.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Cancer Center at UC Health Sciences Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2000-05 |
| Est. Completion | 2009-12-01 |
What the finished NCT00897364 record still lists
NCT00897364 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00897364 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00897364 about?
NCT00897364 is a clinical study titled "Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers". RATIONALE: Studying samples of tissue from smokers and non-smokers in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This phase II study is looking at biomarkers in the nose, throat, and lung tissue of smokers and non-smokers.
What is the current status of trial NCT00897364?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2000-05. Estimated completion is 2009-12-01.
What conditions does trial NCT00897364 study?
This clinical trial studies the following conditions: Lung Cancer, Precancerous Condition.
Who is sponsoring clinical trial NCT00897364?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00897364 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00897364's enrollment target sits among peer trials
112 176th of 409 higher than 233 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia